Health :: Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals

Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.

Rheumatoid Arthritis :: ORENCIA, abatacept demonstrate continued efficacy in adults with rheumatoid arthritis

Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA? (abatacept) in adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and TNF antagonists. The data also demonstrate that ORENCIA provided clinically meaningful improvements in multiple aspects of health-related quality of life and physical function, sustained improvements in pain and had a consistent safety and tolerability profile through two years of treatment. These data will be presented at the upcoming 2006 American College of Rheumatology (ACR) Annual Scientific Meeting.

Cancer :: Firefighters face increased risk for certain cancers

University of Cincinnati (UC) environmental health researchers have determined that firefighters are significantly more likely to develop four different types of cancer than workers in other fields. Their findings suggest that the protective equipment firefighters have used in the past didn’t do a good job in protecting them against cancer-causing agents they encounter in their profession, the researchers say.

Stem Cell :: Cure for blindness – stem cell transplant in eyes – UK

A team of international researchers has transferred eye tissue from newborn to adult mice. It lets the blind adults detect light. The scientists say it challenges conventional wisdom on stem cells, because the successful cells had already stopped dividing before they were transferred.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack